Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial
Rafael de la Torre, Susana de Sola, Gimena Hernandez, Magí Farré, Jesus Pujol, Joan Rodriguez, Josep María Espadaler, Klaus Langohr, Aida Cuenca-Royo, Alessandro Principe, Laura Xicota, Nathalie Janel, Silvina Catuara-Solarz, Gonzalo Sanchez-Benavides, Henri Bléhaut, Laura del Hoyo, Bessy Benejam, Laura Blanco-Hinojo, Sebastiá Videla, Montserrat FitóJean Maurice Delabar, Mara Dierssen, Ester Civit, Gonzalo Sanchez, Ivan Dueñas-Espín, Laia Roca, Valérie Legout, Judit Sánchez-Gutiérrez, Katy Trias, Rut Freixas
Dive into the research topics of 'Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): A double-blind, randomised, placebo-controlled, phase 2 trial'. Together they form a unique fingerprint.